Skip to main content
. 2019 Sep 26;105(7):1948–1956. doi: 10.3324/haematol.2019.227876

Figure 2.

Figure 2

Use of low molecular weight heparin in inherited platelet disorder patients according to venous thromboembolism risk classes. Use of LMWH in IPD patients according to A) Caprini VTE class risk and B) procedure related VTE-risk (*P<0.01 vs. high-risk). LMWH: low molecular weight heparin; IPD: inherited platelet disorder; VTE: venous thromboembolism.